Enhanced serum IgA concentrations are common in alcoholic liver cirrhosis, but functional differences between IgA subclasses and their relation with interleukin-6 (IL-6) have not been described. Distinct immunoregulatory mechanisms may exist that selectively affect one subclass. This possibility prompted us to investigate the distribution of IgAl and IgA2 subclasses in the serum of 25 heavy alcohol drinkers (alcohol: 80 to 200 g per day) without clinical disorders, in comparison with 35 patients affected by alcoholic liver cirrhosis, 29 viral hepatitis patients and 33 social drinkers as a control group. Mean (± SD) IgA2 concentration (0.56 ± 0.31 g/1) was significantly increased (p < 0.01) in heavy alcohol drinkers, with an IgA2/IgAl ratio of 0.33 ± 0.12, while the mean total IgA concentration was similar to the control group. Mean IgAl and IgA2 concentrations were significantly increased (p < 0.001) in alcoholic liver cirrhosis patients (6.13 ± 4.52 g/1 and 1.83 ± 1.93 g/1 respectively, with an IgA2/IgAl ratio of 0.32 ± 0.19) and viral hepatitis patients (3.66 ± 2.59 g/1 and 0.69 ± 0.67 g/1 respectively, with an IgA2/IgAl ratio of 0.21 ±0.14) High serum IL-6 concentrations (34 ± 33 ng/1) were correlated with elevated IgAl and IgA2 concentrations only in patients with alcoholic liver cirrhosis. IgA2 subclass and IgA2/IgAl ratio could therefore be used as markers of chronic alcohol abuse directly related to the extent and duration of the alcohol abuse and the effectiveness of alcohol withdrawal.
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Tab. 1 Hepatic characteristics (mean ± SD (median)) of the studied population. -Twenty-five heavy alcohol drinkers (10 women and 15 men, mean age ± SD: 52 ± 10 years, range: 35-70 years) who had ingested more than 80 g alcohol daily for at least five consecutive years without clinical or biological signs of liver disease were volunteers for a course of alcohol withdrawal.
-Thirty-five patients (7 woman and 28 men, mean age ± SD: 48 ±11 years, range: 31 -74 years) with alcoholic liver cirrhosis were grouped according to the Child-Pugh classification (11). They were studied at least two months after cessation of alcohol intake. In all cases, cirrhosis was due to chronic alcohol ingestion and confirmed by histology. None of the patients had overt signs of viral hepatic infection.
-Twenty-nine patients (12 women and 17 men, mean age ± SD: 50 ±15 years, range: 17-71 years) with viral hepatitis B (n = 13), C (n = 11) and non-A, non-B, non-C (n = 5) were controlled in this study. The hepatitis was diagnosed according to conventional criteria, including serological markers using currently available assays and liver biochemical test abnormalities (alanine amino-transferase > 1.5 the upper normal limit for longer than six months). None of the viral hepatitis patients had liver cirrhosis.
In alcoholic liver cirrhosis and viral hepatitis patients, alcohol ingestion was less than 40 g per day at the time of the sample.
All patients gave their informed consent to the experimental protocol.
Serum samples
Blood samples were collected in sterile, clean, dry tubes and rapidly separated after coagulation. Serum was stored at -20 °C.
Measurement of serum IgA, IgAl and IgA2 concentrations
Concentrations of IgA, and IgAl, IgA2 subclasses in serum were measured by a sandwich time-resolved immunofluorometric assay as previously described (12- The reliability of the reagents used in this assay had been previously verified (specificity 99% for anti-IgAl and 98% for antiIgA2; sensitivity 1 μ^Ι for both subclasses; linearity 10-1000 μg/l for IgAl and 10-400 μg/l for IgA2; intra-assay variations 4.7-6.1%; inter-assay variations 6.7-9.1%) (12) .
Measurement of serum interleukin-6 concentration
Level of IL-6 in serum was measured by means of an enzyme amplified sensitivity immunoassay, performed on a microtitration plate (Medgenix, Fleurus, Belgium). It is based on the oligoclonal system in which several monoclonal antibodies directed against distinct epitopes of IL-6 are used. The assay was performed directly on serum without any treatment or extraction. The amount of substrate (tetramethylbenzidine-H 2 O2) turnover was determined colorimetrically by measuring absorbance at 450 mm.
Statistical analysis
Results were expressed as arithmetic mean ± standard deviation (SD) and median. For the different properties, results were expressed as frequency (%) in comparison with the normal upper limit (mean ± 2 SD) of each property obtained for the control social drinkers. The Mann & Whitney U-test was used to compare the data from each group versus the control group. For correlation studies, Spearman's rank correlation was used. Values of p s 0.05 were taken as significant.
Results
The results of the measurement of IgA, IgAl and IgA2 subclasses and IL-6 concentrations are expressed in Correlations between serum IgA, IgAl and IgA2, and interleukin-6 concentrations
In the heavy alcohol drinkers, IgAl and IgA2 concentrations were positively correlated (p < 0.01). In contrast, in alcohol liver cirrhosis and viral hepatitis patients, the elevated IgAl and IgA2 serum concentrations were inversely correlated. In patients with alcoholic liver cirrhosis, a significant positive correlation (p < 0.01) was observed between elevated IgAl and IgA2 concentrations and IL-6 secretion.
Discussion
The reliability criteria for the time-resolved immunofluorometric assay used for the measurement of total IgA and IgAl, and IgA2 subclasses were very satisfactory. This non-isotopic method is simple to perform and its high sensitivity makes it suitable for the determination of serum IgAl and IgA2 concentrations in patients with alcoholic liver disease.
(p < 0.01), with a predominance of IgA2. The IgA2/ IgAl ratio was elevated in 8/25 of patients (32%).
-In alcohol liver cirrhosis patients, the IgA concentration was elevated in 22/35 patients (63%); the prevalence of the elevated concentrations did not differ between IgAl, 20/35 (57%) and IgA2 22/35 (63%). The IgA2/IgAl ratio was elevated in 9/35 patients (26%).
-In viral hepatitis patients, the IgA concentration was elevated in 12/29 patients (41%), the prevalence of elevated concentrations of IgAl, 11/29 (38%) and IgA2 5/29 (17%) differed significantly (p <0.01), with a predominance of IgAl. The IgA2/IgAl ratio was elevated in 3/29 patients (10%).
Serum concentration of interleukin-6
Mean IL-6 concentration was significantly increased in patients with alcohol liver cirrhosis (p < 0.001) and in viral hepatitis patients (p < 0.05). In this last group, there was a wide range of values (3 -1230 ng/1). In these two groups, the prevalence of elevated concentrations of IL-6 was 10/17 (59%) and 12/23 (52%) respectively, and did not significantly differ.
Heavy alcohol drinkers and alcoholic cirrhosis patients
In the heavy alcohol drinkers and the alcoholic liver cirrhosis patients, in whom the alcohol factor was present, the study showed an increased IgA2/IgAl ratio. Whatever the total IgA concentration, the ratios in the heavy drinkers and alcoholic cirrhosis patients (0.33 ± 0.12 and 0.32 ±0.19, respectively) were significantly different from the control social drinkers and the viral hepatitis patients. This agrees with our previous studies in which serum IgA subclass distributions were anlyzed in alcohol liver disease (9) . The increase in IgA2/IgAl ratio could constitute a diagnostic or predictive marker in heavy alcohol drinkers (prevalence: 32%) evolving to cirrhosis (26%), while this prevalence in viral hepatitis patients is 10%. In heavy alcoholic drinkers without clinical liver disease, microvascular changes in the intestinal tract may be considered as the cause of the plasma protein loss into the jejunal lumen demonstrated by Buell & Beck, and Ray et al. in the dog (16, 17) . Several studies have shown the direct toxic effects of alcohol on intestinal epithelial cells and hepatocytes (18, 19) . In particular, loss of superficial cells and damage to the upper layer of mucosa can be observed in the intesti-nal epithelium (20) . These morphological changes in the small bowel epithelium are found even in the absence of cirrhosis (21) . Alcohol increases intestinal permeability to macromolecules whatever the degree of hepatic dysfunction (22) . The primary effect of alcohol may be the release of pro-inflammatory mediators such as rumour necrosis factor-and IL-6 that can increase intestinal permeability and local immunoglobulin secretion. Seilies et al. observed too that serum secretory IgA and free secretory component concentrations were significantly increased in patients with chronic alcoholic liver disease, even at a very early stage of the disease, and decreased after alcohol withdrawal (23) .
Alcoholic liver cirrhosis patients
In alcoholic liver cirrhosis patients, the observation of an increase in both serum IgAl and IgA2 concentrations with frequencies of 57% and 67% respectively, as well as the positive correlation with IL-6 concentration, seems to be a major abnormality due to an immune response against many intestinal antigens and cytokine production. IL-6 is responsible for subsequent activation of B cells, resulting in their differentiation into IgA-secreting plasma cells.
The marked increase in total serum IgA concentrations in patients with cirrhosis could be due to a secondary effect of the initial release of free secretory component/ secretory IgA to the plasma compartment, leading to abnormalities in cytokine regulation (24) (25) (26) . In addition, the abnormal permeability of the intestinal barrier in alcoholic liver cirrhosis patients could allow an increased antigenic load in the plasma as food antigens and lipopolysaccharide (27) . Increased IgA synthesis may reflect this increased antigenic load and the diminished T-cell suppression, or T-cell independent B-cell stimulation (8, 28) . The IgA2 antibodies also have lipopolysaccharide and other amphiphilic components of Gram-negative bacteria as targets (29) (30) . Moreover, peripheral blood mononuclear cells from patients with alcoholic liver cirrhosis show an increased lipopolysaccharide-induced IL-6 secretion, which has been correlated with increased IgA serum concentrations (10, 26) .
Recently, Guillemin et al. have shown that IgA faecal output was increased in alcoholic liver cirrhosis patients in comparison with control social drinkers (31) . This observation confirms the possible role of the gut-associated lymphoid tissue in the serum IgA subclass metabolism.
Intestinal IgA synthesis may be stimulated in alcohol liver cirrhosis patients and could help explain the serum IgA2 subclass origin also. This IgA2 subclass formed the major subclass contributing to the continuous pattern of IgA deposition in hepatic tissues (8) . The role of this subclass seems very important in the extent of the liver damage and its serum increase may be related to alcohol consumption.
Viral hepatitis patients
In viral hepatitis patients, while there is an increase in serum IgA2 subclass, the absence of any difference in the IgA2/IgAl ratio from the control social drinkers suggests that the IgA metabolism is different in heavy alcohol drinkers and alcoholic liver cirrhosis patients. The pro-inflammatory cytokines (IL-6) induce IgA secretion in both subclasses. The lower significance of the serum IL-6 increase in viral hepatitis patients than in alcoholic liver cirrhosis patients may be explained by the marked heterogeneity of this group (nature of the virus, severity of the infection). In fact, in viral hepatitis patients, there are probably only slight disturbances in the intestinal permeability, but the IgA metabolism seems to be profoundly disturbed.
Conclusion
The measurement of serum IgA sbuclasses and IgA2/ IgAl ratio in patients with either normal or elevated serum total IgA could provide a means to detect alcoholic liver patients that are heavy alcoholic drinkers or viral hepatitis patients evolving to clinical complications such as cirrhosis or damage to the gastro-intestinal tract. In these situations, the IgA2 subclass, and the IgA2/IgAl ratio in particular, could be specific markers of chronic alcohol abuse directly related to the extent and duration of the alcohol abuse. However, further studies are required to confirm this, including a longitudinal study in heavy drinkers evolving to cirrhosis.
